Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
Headache rate and cost of care following lumbar puncture at a single tertiary care hospital
Neurol 77:71-74, Dakka, Y.,et al, 2011
Triptan Therapy in Migraine
NEJM 363:63-70, Loder,E., 2010